Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.

Members of the Oxford and Brazilian delegations toast the signing of the agreement © Cyrus Mower (cyrusoxford.co.uk)

The unit – the first of its kind that Oxford has developed in the Americas – will work on developing new drugs and vaccines to drive ongoing human health research. It will also focus on training a new generation of clinical researchers by offering Master’s, PhD studentships and courses in infectious diseases, clinical development and vaccinology.

The COVID-19 pandemic has brought the risk of life-threatening infectious diseases into sharp focus, and both the University and their Brazilian counterparts initially aim to drive research to better prepare and respond to health risks by focussing on COVID-19 vaccines and treatments before potentially branching out into other clinical areas.

The unit is also a culmination of a strong relationship the University has built with Brazilian researchers during the pandemic.

Read the full story on the University of Oxford website

Similar stories

Oxford University wins prestigious Queen’s Anniversary Prize

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.